Trial Profile
Inhaled Nitric Oxide and Transfusion Therapy for Patients With Sickle Cell Anemia and Secondary Pulmonary Hypertension
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary) ; Arginine; Bosentan; Epoprostenol; Oxygen; Sildenafil
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 25 May 2014 New trial record
- 25 May 2014 New trial record